El día 2 de noviembre de 2018 el Dr. Fernando Nistal de Paz (adjunto MI) repasó varios artículos en base a tres temas:
- Cardiomiopatía amiloide por transtiretina:
– Wild-type transthyretin amyloidosis as a cause of heart failure with preserved ejection fraction.
-Tafamidis treatment for patients with transthyretin amyloid cardiomyopathy.
-Aspirin for the primary prevention of cardiovascular events: a systematic evidence review for the US Preventive Services Task Force.
-Effects of aspirin for primary prevention in persons with diabetes mellitus.
-Effects of n-3 fatty acid supplements in diabetes mellitus.
-Use of aspirin to reduce risk of initial vascular events in patients at moderate risk of cardiovascular disease (ARRIVE): a randomised, double-blind, placebo-controlled trial.
-Effect of aspirin on all cause mortality in the healthy elderly.
-Effect of aspirin on cardiovascular events and bleeding in the healthy elderly.
-Effect of aspirin on disability free survival in the healthy elderly.
- Cambios en diabetes tipo 2:
-Guía de Consenso ADA & EASD (Berlin 5/10/2018).
La presentación se puede descargar aquí.